Skip to content
★ Sign in to follow
KP

K. Peony Yu

Board Director
Director
Total declarations
115
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (52 ops.)
€11.5M

Latest filing published 16 Jun 2023 for Staar Surgical Co.

Filing timeline

BuySale
K. Peony Yu

Insider track record

Disclosed buys
0
Disclosed sells
52
Signal history

K. Peony Yu: trading record in brief

Filings by K. Peony Yu span 2 companies, the busiest being Kyntra Bio, Inc. and Staar Surgical Co. We count 115 filings; the first trade dates from 13 November 2014 and the latest from 15 June 2023.

No open-market purchase appears, only 52 sales worth €11.5M. Outside the open market, there are 42 share grants and 21 option exercises.

The record was last updated on 16 June 2023 with an option exercise in Staar Surgical Co. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to K. Peony Yu

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations114 total
  • ◇
    DirectorExecutivesStaar Surgical Co
    0SEC
    1,709 shares0Common StockSEC:0001209191-23-038169:0
  • ◇
    DirectorExecutivesStaar Surgical Co
    0SEC
    355 shares0Common StockSEC:0001209191-22-038111:0
  • ◆
    DirectorExecutivesStaar Surgical Co
    0SEC
    404 shares0Common StockSEC:0001209191-21-043367:0
  • ◆
    DirectorExecutivesStaar Surgical Co
    0SEC
    318 shares0Common StockSEC:0001209191-21-005474:0
  • ▼
    Chief Medical OfficerExecutivesKyntra Bio, Inc.
    139,394 USD24SEC
    3,350 shares@ US$41.619.0% of flowCommon StockSEC:0001209191-20-064228:0
  • ◆
    Chief Medical OfficerExecutivesKyntra Bio, Inc.
    138,231 USD12SEC
    3,292 shares@ US$41.999.0% of flowCommon StockSEC:0001209191-20-062620:0
  • ▼
    Chief Medical OfficerExecutivesKyntra Bio, Inc.
    147,478 USD24SEC
    3,351 shares@ US$44.017.4% of flowCommon StockSEC:0001209191-20-051174:0
  • ◆
    Chief Medical OfficerExecutivesKyntra Bio, Inc.
    138,749 USD12SEC
    3,291 shares@ US$42.167.0% of flowCommon StockSEC:0001209191-20-050052:0
  • ◇
    Chief Medical OfficerExecutivesKyntra Bio, Inc.
    180,000 USD12SEC
    10,000 shares@ US$18.009.0% of flowCommon StockSEC:0001209191-20-049620:0
  • ▼
    Chief Medical OfficerExecutivesKyntra Bio, Inc.
    508,900 USD26SEC
    10,000 shares@ US$50.8925.5% of flowCommon StockSEC:0001209191-20-049620:1
  • ▼
    Chief Medical OfficerExecutivesKyntra Bio, Inc.
    141,915 USD12SEC
    3,351 shares@ US$42.357.3% of flowCommon StockSEC:0001209191-20-043888:0
  • ◆
    Chief Medical OfficerExecutivesKyntra Bio, Inc.
    110,644 USD11SEC
    3,292 shares@ US$33.614.8% of flowCommon StockSEC:0001209191-20-035695:0
  • ◆
    Chief Medical OfficerExecutivesKyntra Bio, Inc.
    390,190 USD13SEC
    9,826 shares@ US$39.7117.1% of flowCommon StockSEC:0001209191-20-020123:0
  • ◇
    Chief Medical OfficerExecutivesKyntra Bio, Inc.
    72,713 USD11SEC
    3,750 shares@ US$19.393.2% of flowCommon StockSEC:0001209191-20-020123:1
  • ◆
    Chief Medical OfficerExecutivesKyntra Bio, Inc.
    0SEC
    45,000 shares0Common StockSEC:0001209191-20-020123:2
  • ▼
    Chief Medical OfficerExecutivesKyntra Bio, Inc.
    159,646 USD23SEC
    3,420 shares@ US$46.682.8% of flowCommon StockSEC:0001209191-19-061054:0
  • ◇
    Chief Medical OfficerExecutivesKyntra Bio, Inc.
    9,579 USD11SEC
    657 shares@ US$14.580.2% of flowCommon StockSEC:0001209191-19-059539:0
  • ◇
    Chief Medical OfficerExecutivesKyntra Bio, Inc.
    63,000 USD11SEC
    3,500 shares@ US$18.001.1% of flowCommon StockSEC:0001209191-19-059539:1
  • ◆
    Chief Medical OfficerExecutivesKyntra Bio, Inc.
    159,230 USD11SEC
    3,360 shares@ US$47.392.8% of flowCommon StockSEC:0001209191-19-059539:2
  • ▼
    Chief Medical OfficerExecutivesKyntra Bio, Inc.
    139,905 USD29SEC
    3,419 shares@ US$40.922.3% of flowCommon StockSEC:0001209191-19-050170:0
  • ◆
    Chief Medical OfficerExecutivesKyntra Bio, Inc.
    346,653 USD12SEC
    8,317 shares@ US$41.685.8% of flowCommon StockSEC:0001209191-19-049101:0
  • ◇
    Chief Medical OfficerExecutivesKyntra Bio, Inc.
    155,977 USD11SEC
    10,698 shares@ US$14.582.4% of flowCommon StockSEC:0001209191-19-037285:0
  • ▼
    Chief Medical OfficerExecutivesKyntra Bio, Inc.
    140,083 USD26SEC
    3,420 shares@ US$40.962.2% of flowCommon StockSEC:0001209191-19-037285:1
  • ◆
    Chief Medical OfficerExecutivesKyntra Bio, Inc.
    128,722 USD11SEC
    3,360 shares@ US$38.312.0% of flowCommon StockSEC:0001209191-19-035681:0
  • ▼
    Chief Medical OfficerExecutivesKyntra Bio, Inc.
    514,864 USD30SEC
    9,145 shares@ US$56.306.9% of flowCommon StockSEC:0001209191-19-019802:0

25 of 114 declarations